Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.41 |
| ▸ | ACACB | O00763 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16552364 | 0.90 | MAOB (0.42) | MAOBITGB3ITGA2BACACB | |
| SCHEMBL16552371 | 0.88 | MAOB (0.41) | MAOBITGB3ITGA2BACACB | |
| SCHEMBL17935575 | 0.86 | MAOB (0.57) | MAOBITGB3ITGA2BACACB | |
| SCHEMBL17935604 | 0.85 | MAOB (0.55) | MAOB | |
| SCHEMBL17931622 | 0.83 | ACACB (0.36) | MAOBACACB | |
| SCHEMBL17935565 | 0.75 | LTA4H (0.49) | — | |
| SCHEMBL16552399 | 0.74 | MAOB (0.56) | MAOB | |
| SCHEMBL22304893 | 0.73 | LTA4H (0.37) | ITGB3ITGA2BACACB | |
| SCHEMBL17931620 | 0.72 | ACACB (0.37) | MAOBACACB | |
| SCHEMBL16552369 | 0.72 | MAOB (0.54) | MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160207878-A1 | MAO-B Selective Inhibitor Compounds, Pharmaceutical Compositions Thereof and Uses Thereof | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2016-07-21 | — | — | US | disclosed |
| WO-2015027324-A1 | MAO-B SELECTIVE INHIBITOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2015-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160207878-A1 | MAO-B Selective Inhibitor Compounds, Pharmaceutical Compositions Thereof and Uses Thereof | MAOB, MAOA, COMT | MAOB 1/4885ITGB3 1939/4885ITGA2B 1154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.